Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

被引：24

作者：

Song, Kevin W. ^{[1
]}

Dimopoulos, Meletios A. ^{[2
]}

Weisel, Katja C. ^{[3
]}

Moreau, Philippe ^{[4
]}

Palumbo, Antonio ^{[5
,6
]}

Belch, Andrew ^{[7
]}

Schey, Stephen ^{[8
,9
]}

Sonneveld, Pieter ^{[10
]}

Sternas, Lars ^{[11
]}

Yu, Xin ^{[11
]}

Amatya, Ramesh ^{[12
]}

Monzini, Mara S. ^{[11
]}

Zaki, Mohamed ^{[11
]}

Jacques, Christian ^{[11
]}

Miguel, Jesus San ^{[13
]}

机构：

[1] Vancouver Gen Hosp, Vancouver, BC, Canada

[2] Alexandra Hosp, Athens, Greece

[3] Univ Tubingen Hosp, Tubingen, Germany

[4] Univ Hosp Hotel Dieu, Nantes, France

[5] Univ Hosp, Milan, Italy

[6] Hlth City Sci Torino, Turin, Italy

[7] Univ Alberta, Edmonton, AB, Canada

[8] Kings Coll Hosp London, London, England

[9] Kings Coll London, London WC2R 2LS, England

[10] Erasmus MC, Rotterdam, Netherlands

[11] Celgene Corp, Summit, NJ USA

[12] Adelphi Values, Boston, MA USA

[13] Hosp Univ Salamanca, Salamanca, Spain

来源：

HAEMATOLOGICA | 2015年 / 100卷 / 02期

关键词：

Pomalidomide; quality of life; multiple myeloma; EORTC QLQ-C30; SURVIVAL; BORTEZOMIB; DISEASE; EQ-5D;

D O I：

10.3324/haematol.2014.112557

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：E63 / E67

页数：5

共 50 条

[31] A health-related quality-of-life (HRQoL) analysis of pomalidomide plus low-dose dexamethasone plus daratumumab in relapsed refractory multiple myeloma (RRMM) after lenalidomide treatment.
Reece, Donna Ellen
Bahlis, Nizar J.
Samaras, Christy Joy
Sebag, Michael
Berdeja, Jesus G.
Ganguly, Siddartha
Matous, Jeffrey
Song, Kevin W.
Seet, Christopher
Talamo, Giampaolo
Acosta-Rivera, Mirelis
Bar, Michael
Quick, Donald
Anz, Bertrand Marquess
Fonseca, Gustavo A.
Agarwal, Amit
Chung, Weiyuan
Zafar, Faiza
Siegel, David Samuel DiCapua
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[32] Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
Attal, Michel
Richardson, Paul G.
Rajkumar, S. Vincent
San-Miguel, Jesus
Beksac, Meral
Spicka, Ivan
Leleu, Xavier
Schjesvold, Fredrik
Moreau, Philippe
Dimopoulos, Meletios A.
Huang, Jeffrey Shang-Yi
Minarik, Jiri
Cavo, Michele
Prince, H. Miles
Mace, Sandrine
Corzo, Kathryn P.
Campana, Frank
Le-Guennec, Solenn
Dubin, Franck
Anderson, Kenneth C.
[J]. LANCET, 2019, 394 (10214): : 2096 - 2107
[33] Final Analysis, Cytogenetics, Long-Term Treatment, and Long-Term Survival In MM-003, A Phase 3 Study Comparing Pomalidomide plus Low-Dose Dexamethasone (POM plus LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM)
Dimopoulos, Meletios A.
Weisel, Katja
Song, Kevin W.
Delforge, Michel
Karlin, Lionel
Goldschmidt, Hartmut
Moreau, Philippe
Banos, Anne
Oriol, Albert
Garderet, Laurent
Cavo, Michele
Ivanova, Valentina
Alegre, Adrian
Lopez, Joaquin Martinez
Chen, Christine I.
Spencer, Andrew
Knop, Stefan
Bahlis, Nizar J.
Renner, Christoph
Yu, Xin
Hong, Kevin
Sternas, Lars
Jacques, Christian
Zaki, Mohamed H.
San Miguel, Jesus F.
[J]. BLOOD, 2013, 122 (21)
[34] Selinexor Plus Pomalidomide and Low Dose Dexamethasone (SPd) in Patients with Relapsed or Refractory Multiple Myeloma
Chen, Christine I.
Sutherland, Heather J.
Kotb, Rami
Sebag, Michael
White, Darrell J.
Bensinger, William
Gasparetto, Cristina J.
Leblanc, Richard
Venner, Christopher P.
Lentzsch, Suzanne
Schiller, Gary J.
Lipe, Brea
Del Col, Aldo
Shah, Jatin J.
Jeha, Jacqueline
Saint-Martin, Jean-Richard
Kauffman, Michael G.
Shacham, Sharon
Bahlis, Nizar
[J]. BLOOD, 2018, 132
[35] Health-Related Quality of Life With Pomalidomide plus Dexamethasone plus Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients
Reece, Donna
Bahlis, Nizar J.
Samaras, Christy Joy
Sebag, Michael
Berdeja, Jesus
Ganguly, Siddhartha
Matous, Jeffrey
Song, Kevin
Seet, Christopher S.
Talamo, Giampaolo
Acosta-Rivera, Mirelis
Bar, Michael
Quick, Donald
Anz, Bertrand
Fonseca, Gustavo
Agarwal, Amit
Chung, Weiyuan
Zafar, Faiza
Siegel, David S.
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E277 - E278
[36] Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial
Dimopoulos, Meletios
Weisel, Katja
van de Donk, Niels W. C. J.
Ramasamy, Karthik
Gamberi, Barbara
Streetly, Matthew
Offidani, Massimo
Bridoux, Frank
de la Rubia, Javier
Mateos, Maria-Victoria
Ardizzoia, Antonio
Kueenburg, Elisabeth
Collins, Shona
Di Micco, Antonia
Rosettani, Barbara
Li, Yan
Bacon, Pamela
Sonneveld, Pieter
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (20) : 2035 - +
[37] Phase III trial of thalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma
不详
[J]. CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 452 - 453
[38] Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Isatuximab Plus Pomalidomide and Dexamethasone: Icaria-MM Study
Houghton, Katherine
Dimopoulos, Meletios A.
Lin, Peggy
Guillonneau, Sophie
Bury, Denise
Attal, Michel
Richardson, Paul G.
Delforge, Michel
[J]. BLOOD, 2019, 134
[39] MM-011: A Phase 2 Study of Pomalidomide Plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma in Japan
Hagiwara, Shotaro
Okamoto, Shinichiro
Matsue, Kosei
Iida, Shinsuke
Sunami, Kazutaka
Komeno, Takuya
Suzuki, Kenshi
Ando, Kiyoshi
Taniwaki, Masafumi
Tobinai, Kensei
Chou, Takaaki
Kaneko, Hitomi
Iwasaki, Hiromi
Uemura, Chie
Tamakoshi, Hiromi
Zaki, Mohamed H.
Doerr, Thomas
Kuroda, Yoshiaki
Ichinohe, Tatsuo
[J]. BLOOD, 2015, 126 (23)
[40] THE STRATUS TRIAL (MM-010): ANALYSIS OF THE ITALIAN SUBGROUP OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE
Cavo, M.
Corradini, P.
Di Raimondo, F.
Vacca, A.
Petrini, M.
Cafro, A. M.
di Toritto, T. Caravita
Offidani, M.
Semenzato, G.
Zambello, R.
Lazzaro, A.
Patriarca, F.
Petrucci, M. T.
Rodeghiero, F.
Simcock, M.
Slaughter, A.
Herring, J.
Peluso, T.
Palumbo, A.
[J]. HAEMATOLOGICA, 2016, 101 : 795 - 795

← 1 2 3 4 5 →